Apyx Medical (APYX) Accounts Payables (2010 - 2026)

Apyx Medical's Accounts Payables history runs 17 years deep, the most recent figure standing at $2.6 million for Q1 2026.

• Quarterly Accounts Payables rose 14.06% year-over-year to $2.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.6 million (up 14.06% YoY) and the FY2025 annual result came in at $3.1 million, up 16.94% from the prior year.
• Accounts Payables was $2.6 million for Q1 2026 at Apyx Medical, down from $3.1 million in the prior quarter.
• Across five years, Accounts Payables topped out at $3.2 million in Q3 2025 and bottomed at $1.9 million in Q1 2023.
• A 5-year average of $2.5 million and a median of $2.6 million in 2022 frame the typical range for Accounts Payables.
• Annual changes were most pronounced in 2022 — Accounts Payables sank 32.0% — and 2025, when it soared 68.23%.
• Apyx Medical's Accounts Payables stood at $2.7 million in 2022, then increased by 1.61% to $2.7 million in 2023, then dropped by 3.58% to $2.6 million in 2024, then grew by 16.94% to $3.1 million in 2025, then declined by 14.03% to $2.6 million in 2026.
• Business Quant data shows APYX's Accounts Payables at $2.6 million in Q1 2026, $3.1 million in Q4 2025, and $3.2 million in Q3 2025.